Biotron BIT announces almost Cure for HEP C, page-4

  1. Fingers xed
    7,601 Posts.
    lightbulb Created with Sketch. 959
    clock Created with Sketch.
    17/03/16
    14:33
    Post #: 17300813
    Business Breaking News
    Biotron positive after phase 2 trial

    15 minutes ago
    AAP



    Biotron positive after phase 2 trial
    Biotron has received positive results from its phase 2 study of antiviral drug BIT225, with the number of Hepatitis C patients recovering much higher.

    The drug was safe and well-tolerated and provides key data on the performance of the capsule formulation.
    The company will look to use this data for an upcoming phase 2 trial on HIV-1 patienrs, starting mid-2016.
    The above article appeared on Perth Now's website this morning.  FYI
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.